• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007

Comprehensive Overview of N-[(Z)-(3,4-Dihydroxyphenyl)methylideneamino]-3-hydroxynaphthalene-2-carboxamide hydrate (CAS No. 1202867-00-2)

N-[(Z)-(3,4-Dihydroxyphenyl)methylideneamino]-3-hydroxynaphthalene-2-carboxamide hydrate (CAS No. 1202867-00-2) is a synthetic organic compound with a unique molecular structure that combines a naphthalene core with a dihydroxyphenyl moiety. This compound has garnered significant attention in recent years due to its potential applications in pharmaceutical research, material science, and biochemical studies. Researchers are particularly interested in its chelating properties and its ability to interact with biological systems, making it a subject of ongoing studies in drug discovery and molecular imaging.

The compound's hydrate form enhances its stability and solubility, which is crucial for its use in aqueous solutions and biological assays. Its Z-configuration and hydroxyl-rich structure contribute to its reactivity, enabling it to participate in various chemical reactions, such as Schiff base formation and metal coordination. These properties make it a versatile intermediate in the synthesis of more complex molecules, particularly those targeting oxidative stress-related pathways or enzyme inhibition.

In the context of current research trends, N-[(Z)-(3,4-Dihydroxyphenyl)methylideneamino]-3-hydroxynaphthalene-2-carboxamide hydrate aligns with the growing interest in multifunctional compounds that can address neurodegenerative diseases and inflammatory conditions. Its antioxidant potential is a key area of exploration, as it may offer insights into free radical scavenging mechanisms. Additionally, its fluorescence properties have sparked interest in bioimaging applications, where it could serve as a probe for cellular processes.

From a synthetic chemistry perspective, the compound's CAS No. 1202867-00-2 is often referenced in patent literature and academic publications, highlighting its role in the development of novel therapeutics. Its structure-activity relationship (SAR) is under investigation to optimize its bioavailability and target specificity. This aligns with the broader precision medicine movement, where tailored molecular designs are prioritized for personalized treatment strategies.

The safety profile and environmental impact of N-[(Z)-(3,4-Dihydroxyphenyl)methylideneamino]-3-hydroxynaphthalene-2-carboxamide hydrate are also critical considerations. While it is not classified as a hazardous substance, researchers emphasize responsible handling and waste management to minimize ecological risks. Its biodegradability and toxicity thresholds are subjects of ongoing eco-toxicological studies, reflecting the scientific community's commitment to sustainable chemistry.

In summary, N-[(Z)-(3,4-Dihydroxyphenyl)methylideneamino]-3-hydroxynaphthalene-2-carboxamide hydrate (CAS No. 1202867-00-2) represents a promising compound at the intersection of medicinal chemistry and materials science. Its multifunctional design and adaptable properties make it a valuable tool for addressing some of the most pressing challenges in modern science, from disease treatment to advanced diagnostics.

• 870514-38-8(Benzoic acid, 2-hydroxy-, (2-naphthalenylmethylene)hydrazide, (E)-)
• 5553-46-8(Benzeneacetamide, a-ethoxy-N-methyl-N-[2-[methyl(2-oxo-2-phenylethyl)amino]ethyl]-a-phenyl-, hydrochloride (1:1))
• 1108233-34-6(3,4-Dihydroxy-N’-(2-hydroxybenzylidene)benzohydrazide Hemimethanolate Sesquihydrate)
• 304448-55-3(Dynasore)
• 18269-02-8(Benzoic acid,2-hydroxy-, 2-(phenylmethylene)hydrazide)
• 870514-37-7(Benzoic acid, 3,4-dihydroxy-, (2-naphthalenylmethylene)hydrazide, (E)-)
• 54009-54-0(Benzoic acid,2-hydroxy-, 2-[(2-hydroxy-1-naphthalenyl)methylene]hydrazide)
• 3232-36-8(SCS)
• 80648-84-6(Ytterbium(III) Ionophore II)
• 304481-60-5(KM91104)